Practical Considerations and Rationale for Glucagon-like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes
Goldenberg, Ronald M., Ahooja, Vineeta, Clemens, Kristin K., Gilbert, Jeremy D., Poddar, Megha, Verma, SubodhJournal:
Canadian Journal of Diabetes
DOI:
10.1016/j.jcjd.2020.09.005
Date:
September, 2020
File:
PDF, 1.44 MB
2020